HIGHLIGHTS
- who: Mei Han from the Research Centers (HZ), Germany Complutense University of Madrid have published the Article: Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice, in the Journal: Gut microbiota with significant differences in abundance between experimental samples were identified using the non-parametric Kruskal-Wallis sum-rank test. Other continuous data were analyzed using oneway analysis of variance (ANOVA), and significant of 05/01/2023
- what: The authors investigated the effects of Lacticaseibacillus rhamnosus Hao9 on T2DM in mice with high-fat . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.